Skip to main content
SpringerLink
Log in

Seltene Erkrankungen als Unternehmensstrategie mit Potenzial

  • Biotechnologie
  • Orphan Drugs
  • Published:
BIOspektrum Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Bio.NRW Cluster Biotechnologie Nordrhein-Westfalen, Düsseldorf, Germany

    Bernward Garthoff

  2. Bio.NRW Cluster Biotechnologie Nordrhein-Westfalen, Merowingerplatz 1, D-40225, Düsseldorf, Germany

    Bernward Garthoff

Authors
  1. Bernward Garthoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bernward Garthoff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garthoff, B. Seltene Erkrankungen als Unternehmensstrategie mit Potenzial. Biospektrum 17, 358–359 (2011). https://doi.org/10.1007/s12268-011-0054-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12268-011-0054-y

Search

Navigation